However, despite the lowest coverage observed in the MS analysis of the NPM1 gene, in all other AML cases the comparison between MS and S5 not generated false positive or negative results related to NPM1 gene status, and MS results were confirmed by S5S. The gene discussed is NPM1; the disease is acute myeloid leukemia.